54
Participants
Start Date
July 31, 2016
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Botulinum toxin A
"Researchers discovered in the 1950s that injecting overactive muscles with minute quantities of botulinum toxin type-A would result in decreased muscle activity. Botulinum toxin type-A has this effect because it prevents the vesicle where the acetylcholine is stored from binding to the membrane where the neurotransmitter can be released. Botulinum toxin type-A thus blocks the release of acetylcholine by the neuron. This will effectively weaken the muscle for a period of three to four months.~In addition to its cosmetic applications, Botox is currently used in the treatment of spasms and dystonias, by weakening involved muscles, for the 60-70 day effective period of the drug. The main conditions treated with botulinum toxin are: Cervical dystonia (spasmodic torticollis) (a neuromuscular disorder involving the head and neck), Blepharospasm (excessive blinking) etc.."
cortisone
Saline
RECRUITING
Dep, of Orthopaedic Surgery, Inselspital, University of Berne, Bern
RECRUITING
Department of Orthopaedic Surgery, Kantonsspital Lucerne, Lucerne
Luzerner Kantonsspital
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER